| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 548950000 | The hetero ring contains four members including nitrogen and carbon | 13 |
| 20130123513 | Adhesive Compositions for Bonding Composites - The present invention relates to a non-thermosetting composition made by reacting epichlorohydrin and a primary amine, to the use of that composition for making thermosetting (curable) adhesives suitable for bonding composites, to a method of preparing composites using the thermosetting (curable) adhesives, and to the related composites bonded with the thermosetting (curable) adhesives. | 05-16-2013 |
| 20100222600 | AZETIDINE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS - The invention relates to novel azetidine compounds of formula (I), wherein R | 09-02-2010 |
| 20090069576 | PROCESS FOR PRODUCTION OF 1-(3-(2-(1-BENZOTHIOPHEN-5-YL)-ETHOXY)PROPYL)AZETIDIN-3-OL OR SALTS THEREOF - A Process for production of 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or salts thereof which comprises using as a starting compound as a (phenylthio)acetic acid derivative or salts thereof represented by the general formula: | 03-12-2009 |
| 548952000 | Chalcogen bonded directly to ring carbon of the hetero ring | 5 |
| 20090234139 | Novel Process - A novel process for the preparation of 1′-hydroxy-2′-substituted cyclohexyl azetidin-2-one compound of formula 2, which is important intermediate in the synthesis of trinems, is described by epoxide ring opening of (3S,4R)-3-[(1R)-1-(tert-butyldimethylsilyloxy)ethyl]-4-[(1′R,2′S,3′R)-1′,2′-epoxycyclohexan-3′-yl]azetidin-2-one of formula 1 with the nucleophile compound of formula RYH, where nucleophile may act as solvent itself if the nucleophile is in the liquid form, in a suitable solvent and in the presence of a suitable catalyst from the group of salt of trifluoromethane sulfonic acid, preferably ytterbium (III) trifluoromethanesulfonate, stannous (II) trifluoromethanesulfonate or dysprosium (III) trifluoromethanesulfonate, under a) ultrasonic irradiation or b) under microwave irradiation of the reaction mixture following by isolation and purification of the desired compound. A variant of the novel process describes ring epoxide opening of the starting compound of formula 1 with the compound of formula NH | 09-17-2009 |
| 20100184997 | PROTEIN KINASE C ACTIVITY ENHANCER CONTAINING ALKYL ETHER DERIVATIVE OR SALT THEREOF - Disclosed is a protein kinase C enhancer characterized by containing a benzothiophene alkyl ether derivative represented by the general formula below or a salt thereof. | 07-22-2010 |
| 20080242874 | Direct Aminolysis - In some aspects, the present invention provides a method of preparing a compound of the formula (I) comprising reacting a mesylate compound of the formula (II) by direct aminolysis with a reagent comprising ammonia. The reaction is preferably carried out in a solvent, such as an alcohol, and is preferably carried out in a sealed vessel such as a Parr reactor or the like. | 10-02-2008 |
| 20110098484 | PROCESS FOR PRODUCTION OF 1-(3-(2-(1-BENZOTHIOPHEN-5-YL)- ETHOXY)PROPYL)AZETIDIN-3-OL OR SALTS THEREOF - A Process for production of 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or salts thereof which comprises using as a starting compound as a (phenylthio)acetic acid derivative or salts thereof represented by the general formula: | 04-28-2011 |
| 20110077413 | NOVEL BENZOTHIOPHENE OXIDE DERIVATIVE AND SALT THEREOF - Disclosed is a benzothiophene oxide derivative represented by the general formula (wherein R | 03-31-2011 |
| 548953000 | Nitrogen or -C(=X)-, wherein X is chalcogen, bonded directly to the hetero ring | 5 |
| 20090093644 | METHODS OF SYNTHESIZING CYCLIC NITRO COMPOUNDS - The present invention provides cyclic nitro compounds, pharmaceutical compositions of cyclic nitro compounds and methods of using cyclic nitro compounds and/or pharmaceutical compositions thereof to treat or prevent diseases or disorders characterized by abnormal cell proliferation, such as cancer, inflammation, cardiovascular disease and autoimmune disease. | 04-09-2009 |
| 20110130572 | METHODS OF SYNTHESIZING CYCLIC NITRO COMPOUNDS - The present invention provides cyclic nitro compounds, pharmaceutical compositions of cyclic nitro compounds and methods of using cyclic nitro compounds and/or pharmaceutical compositions thereof to treat or prevent diseases or disorders characterized by abnormal cell proliferation, such as cancer, inflammation, cardiovascular disease and autoimmune disease. | 06-02-2011 |
| 20110118481 | METHOD FOR PREPARING AZETIDINE DERIVATIVES - This invention discloses and claims an industrial method for the production of azetidine derivatives, such as, N-(1-benzhydrylazetidin-3-yl)-N-phenylmethylsulphonamide. | 05-19-2011 |
| 20080319206 | Process for Preparing Protected Amidines - A process for preparing a protected amidine group of formula (I): wherein R | 12-25-2008 |
| 20090299079 | 1-GLYCIDYL-3,3-DINITROAZETIDINE CONTAINING EXPLOSIVE MOIETY AND PREPARATION METHOD THEREOF - Disclosed is a 1-glycidyl-3,3-dinitroazetidine(GDNAZ) of Formula I wherein dinitroazetidine group which is a high energy group having unit structure of explosive moiety is incorporated to a monomer, and the method thereof. By using the GDNAZ of the present invention in the synthesis of energetic binder for high-performance insensitive explosive, an energetic binder with enhanced thermal and storing stability and explosive power can be provided. | 12-03-2009 |
